SEARCH

SEARCH BY CITATION

  • 1
    Maxwell Parkin D. Global cancer statistics in the year 2000. Lancet Oncol 2001; 2: 53343.
  • 2
    Lerose R, Molinari R, Rocchi E, Manenti F, Villa E. Prognostic features and survival of hepatocellular carcinoma in Italy: impact of stage of disease. Eur J Cancer 2001; 37: 23945.
  • 3
    Pietrangele A, Shafritz DA. Gene expression during pathophysiologic states. In: AriasIM, BoyerJL, FaustoN, JakobyWB, SchachterDA, ShafritzDA, editors The liver: biology and pathobiology. Third ed. New York : Raven Press Ltd; 1994. p. 8595.
  • 4
    Courtois G, Morgan JG, Campbell LA., Fourel G, Crabtree GR. Interaction of a liver-specific nuclear factor with the fibrinogen and α1-antitrypsin promoters. Science 1987; 238: 68892.
  • 5
    Cereghini S, Blumenfeld M, Yaniv M. A liver-speciflc factor essential for albumin transcription differs between differentiated and dedifferentiated rat hepatoma cells. Genes & Dev 1988; 2: 95774.
  • 6
    Hardon E, Frain M, Paonessa G, Cortese R. Two distinct factors interact with the promoter regions of several liver specific genes. EMBO J 1988; 7: 17119.
  • 7
    Costa RH, Grayson DR, Darnell JE Jr. Multiple transthyretin and α1-anti trypsin genes. Mol Cell Biol 1989; 9: 141525.
  • 8
    Liang X, Lijian H, Shaohui W, Juakeu G, Ying J, Yanping W, Yuan J, Kin W, Zheguang H, Gengxi H. Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma. Cancer Res 2001; 61: 317681.
  • 9
    Kalkuhl A, Kaestner K, Buchmann A, Schwarz M. Expression of hepatocyte-enriched nuclear transcription factors in mouse liver tumours. Carcinogenesis 1996; 17: 60912.
  • 10
    Flodby P, Liao DZ, Blanck A, Xanthopoulos KG, Hallstrom IP. Expression of the liver-enriched transcription factors C/EBP alpha, C/EBP beta, HNF-1 and HNF-4 in preneoplastic nodules and hepatocellular carcinoma in rat liver. Mol Carcinog 1995; 12: 1039.
  • 11
    Wang W, Hayashi Y, Ninomiya T, Ohta K, Nakabayashi H, Tamaoki T, Itoh H. Expression of HNF-1 alpha and HNF-1 beta in various histological differentiations of hepatocellular carcinoma. J Pathol 1998; 184: 2728.
  • 12
    Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res 1982; 42: 385863.
  • 13
    Nakabayashi H, Taketa K, Yamane T, Miyazaki M, Miyano K, Sato J. Phenotypical stability of a human hepatoma cell line, HuH-7, in long-term culture with chemically defined medium. Gann 1984; 75: 1518.
  • 14
    Alexander JJ, Bey EM, Geddes EW, Lecatsas G. Establishment of a continuously growing cell line from primary carcinoma of the liver. S Afr Med J 1976; 50: 21248.
  • 15
    Yano H, Kojiro M, Nakashima T. A new human hepatocellular carcinoma cell line (KYN-1) with a transformation to adenocarcinoma. In Vitro Cell Dev Biol 1986; 22: 63746.
  • 16
    Haramaki M, Yano H, Fukuda K, Momosaki S, Ogasawara S, Kojiro M. Expression of CD44 in human hepatocellular carcinoma cell lines. Hepatology 1995; 21: 127684.
  • 17
    Yano H, Maruiwa M, Murakami T, Fukuda K, Ito Y, Sugihara S, Kojiro M. A new human pleomorphic hepatocellular carcinoma cell line, KYN-2. Acta Pathol Jpn 1988; 38: 95366.
  • 18
    Murakami T, Maruiwa M, Fukuda K, Kojiro M, Tanaka M, Tanaka M, Tanikawa K. Characterization of a new human hepatoma patient [Abstract]. Proceedings of the 47th annual meeting. Jpn J Cancer Res( Gann ) 1988; 79: 292.
  • 19
    Osada T, Sakamoto M, Ino Y, Iwamatsu A, Matsuno Y, Muto T, Hirohashi S. E-Cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma. Hepatology 1996; 24: 14607.
  • 20
    Hirohashi S, Shimosato Y, Kameya T, Koide T, Mukojima T, Taguchi Y, Kageyama K. Production of alpha-fetoprotein and normal serum proteins by xenotransplanted human hepatomas in relation to their growth and morphology. Cancer Res 1979; 39: 181928.
  • 21
    Shimoyama Y, Gotoh M, Ino Y, Sakamoto M, Kato K, Hirohashi S. Characterization of high-molecular-mass forms of basic fibroblast growth factor produced by hepatocellular carcinoma cells: possible involvement of basic fibroblast growth factor in hepatocarcinogenesis. Jpn J Cancer Res 1991; 82: 126370.
  • 22
    Noguchi M, Hirohashi S. Cell lines from non-neoplastic liver and hepatocellular carcinoma tissue from a single patient. In Vitro Cell Dev Biol-Animal 1996; 32: 1357.
  • 23
    Aden DP, Fogel A, Plotkin S, Damjanov I, Knowles BB. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 1979; 282: 6156.
  • 24
    Beurton F, Bandyopadhyay U, Dieumegard B, Barouki R, Aggerbeck M. Delineation of the insulin-responsive sequence in the rat cytosolic aspartate aminotransferase gene: binding sites for hepatocyte nuclear factor-3 and nuclear factor I. Biochem J 1999; 343: 68795.
  • 25
    Zvibel I, Fiorino AS, Brill S, Reid LM. Phenotypic characterization of rat hepatoma cell lines and lineage-specific regulation of gene expression by differentiation agents. Differentiation 1998; 63: 21523.
  • 26
    Tomizawa M, Watanabe K, Saisho H, Nakagawara A, Tagawa M. Down-regulated expression of the CCAAT/enhancer binding protein alpha and beta genes in human hepatocellular carcinoma: a possible prognostic marker. AnticancerRes 2003; 23: 3514.